Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.29 trillion and total revenue of $116.08 billion.
Market Cap
1.29T
Revenue
116.08B
Profits
-38.07B
PE Ratio
n/a
Profit Margin
-32.80%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.44B | -0.94% | 824,878 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.30B | -2.47% | 540,838 | 15.53B |
| 3 | ARGX | argenx SE | 62.00B | -1.09% | 235,294 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 57.40B | -1.99% | 8,414,686 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.91B | -0.12% | 1,267,651 | - |
| 6 | ONC | BeOne Medicines AG | 39.40B | -2.07% | 257,300 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.62B | -0.98% | 2,732,060 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.88B | -4.69% | 2,175,145 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.53B | -3.71% | 8,104,983 | 7.53M |
| 10 | INSM | Insmed Incorporated | 26.19B | -4.29% | 3,364,509 | 1.14B |
| 11 | INCY | Incyte Corporation | 24.68B | -0.37% | 1,553,682 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.29B | -2.20% | 590,845 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.84B | 4.59% | 3,085,201 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 15.75B | -9.49% | 2,956,308 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -2.05% | 702,580 | 4.60B |
| 16 | EXEL | Exelixis, Inc. | 14.10B | 1.23% | 1,980,423 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.88B | -5.54% | 5,796,293 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.37B | -5.51% | 3,962,304 | 713.07M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.48B | -2.95% | 1,853,709 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | -3.11% | 259,408 | 1.28B |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.06B | -1.57% | 1,055,575 | 1.66B |
| 22 | CORT | Corcept Therapeutics Incorporated | 11.98B | -0.88% | 1,458,655 | 830.81M |
| 23 | TECH | Bio-Techne Corporation | 11.34B | 0.10% | 2,920,451 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.69B | -5.78% | 591,321 | 776.57M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.98B | -12.40% | 4,371,003 | 669.50M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.97B | -0.99% | 225,769 | 440.48M |
| 27 | CYTK | Cytokinetics, Incorporated | 9.64B | -4.33% | 2,576,598 | 67.67M |
| 28 | ABVX | ABIVAX Société Anonyme | 9.44B | -6.09% | 2,007,956 | 5.67M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.41B | -1.29% | 900,882 | 105.00M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.28B | -2.96% | 604,907 | 281.99M |
| 31 | PCVX | Vaxcyte, Inc. | 8.81B | -0.55% | 1,887,866 | - |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -5.34% | 205,651 | 7.46M |
| 33 | TWST | Twist Bioscience Corporation | 8.66B | 2.49% | 1,288,081 | 431.80M |
| 34 | IBRX | ImmunityBio, Inc. | 8.63B | -2.75% | 8,949,305 | 165.79M |
| 35 | CAI | Caris Life Sciences, Inc. | 8.05B | 9.40% | 8,842,496 | 989.61M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.02B | 0.17% | 858,480 | - |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.85B | -8.15% | 6,812,338 | 874.09M |
| 38 | IMVT | Immunovant, Inc. | 7.57B | -2.68% | 1,574,047 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.52B | -1.78% | 1,758,952 | 799.54M |
| 40 | BLTE | Belite Bio, Inc | 6.82B | -2.06% | 151,848 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.66B | -5.53% | 914,269 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.43B | -1.68% | 1,037,317 | 6.23M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.10B | -3.89% | 784,616 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.10B | -2.95% | 927,760 | 618.07M |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.09B | -3.57% | 5,250,473 | - |
| 46 | TVTX | Travere Therapeutics, Inc. | 5.89B | -4.99% | 2,097,797 | 591.33M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.86B | -2.71% | 478,961 | 1.90M |
| 48 | ERAS | Erasca, Inc. | 5.68B | 0.56% | 4,691,502 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 5.68B | -2.01% | 1,712,350 | - |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.52B | -1.31% | 180,222 | 290.54M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.48B | -1.25% | 1,034,202 | 1.01B |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | -3.28% | 587,018 | 7.50M |
| 53 | CRSP | CRISPR Therapeutics AG | 5.01B | -2.13% | 1,248,344 | 13.39M |
| 54 | DFTX | Definium Therapeutics, Inc. | 4.95B | -8.52% | 4,526,872 | - |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.74B | -2.22% | 2,969,594 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.61B | -2.76% | 1,109,417 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.41B | -1.22% | 446,204 | 148.00K |
| 58 | MANE | Veradermics, Incorporated | 4.34B | 2.15% | 938,958 | - |
| 59 | TLX | Telix Pharmaceuticals Limited | 4.30B | 8.91% | 1,078,591 | 890.79M |
| 60 | IOVA | Iovance Biotherapeutics, Inc. | 4.24B | 1.08% | 11,091,432 | 324.97M |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.47% | 2,742,783 | 10.35M |
| 62 | CELC | Celcuity Inc. | 4.05B | -0.99% | 783,502 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.03B | -2.65% | 1,744,572 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 3.91B | -1.97% | 866,955 | - |
| 65 | ABCL | AbCellera Biologics Inc. | 3.70B | 2.15% | 3,728,559 | 66.17M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | -0.97% | 617,082 | 234.13M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.49B | -5.01% | 2,807,989 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | -2.15% | 623,982 | 606.33M |
| 69 | LEGN | Legend Biotech Corporation | 3.42B | -4.64% | 3,477,075 | 1.27B |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.34B | -3.35% | 3,029,307 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.26B | -3.96% | 1,813,874 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.10B | 1.04% | 1,927,929 | 117.00M |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.02B | -1.71% | 686,380 | 158.00K |
| 74 | QURE | uniQure N.V. | 2.99B | -4.07% | 1,214,969 | 18.67M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | -3.13% | 3,459,262 | 463.98M |
| 76 | MBX | MBX Biosciences, Inc. | 2.94B | 2.67% | 652,589 | - |
| 77 | ZLAB | Zai Lab Limited | 2.78B | 0.90% | 937,284 | 449.61M |
| 78 | GPCR | Structure Therapeutics Inc. | 2.78B | 1.33% | 1,470,351 | - |
| 79 | IMNM | Immunome, Inc. | 2.72B | -2.44% | 1,332,793 | 4.02M |
| 80 | PHVS | Pharvaris N.V. | 2.67B | -2.06% | 1,751,076 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.58B | -2.35% | 603,837 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.58B | -2.70% | 1,251,049 | 36.77M |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | -0.14% | 1,781,062 | - |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.53B | -5.37% | 1,732,831 | 7.12M |
| 85 | PGEN | Precigen, Inc. | 2.51B | 2.19% | 2,779,286 | 85.72M |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.47B | -1.67% | 1,210,820 | 71.13M |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 1.52% | 1,212,497 | 959.90M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.43B | -1.12% | 10,493,143 | - |
| 89 | BEAM | Beam Therapeutics Inc. | 2.32B | -3.73% | 2,468,841 | 156.04M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.28B | -3.75% | 5,244,009 | - |
| 91 | NKTR | Nektar Therapeutics | 2.28B | -2.72% | 1,257,781 | 54.59M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.24B | -4.94% | 2,098,595 | 52.06M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.19B | -0.96% | 2,534,666 | 1.97B |
| 94 | PVLA | Palvella Therapeutics, Inc. | 2.18B | -0.31% | 215,611 | - |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.71% | 941,979 | 311.51M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -5.35% | 2,568,290 | - |
| 97 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 0.06% | 715,982 | 1.00M |
| 98 | GENB | Generate Biomedicines, Inc. | 2.08B | 1.19% | 959,203 | 26.48M |
| 99 | KOD | Kodiak Sciences Inc. | 2.07B | -0.45% | 819,594 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.05B | -3.14% | 189,311 | 20.00M |
| 101 | URGN | UroGen Pharma Ltd. | 2.04B | -2.11% | 545,777 | 188.73M |
| 102 | NUVB | Nuvation Bio Inc. | 2.04B | -2.36% | 7,052,347 | 169.90M |
| 103 | VCEL | Vericel Corporation | 2.03B | 0.30% | 654,760 | 306.30M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -1.23% | 1,354,031 | 98.34M |
| 105 | ADMA | ADMA Biologics, Inc. | 1.93B | -5.80% | 3,589,215 | 512.28M |
| 106 | MESO | Mesoblast Limited | 1.91B | -1.86% | 182,498 | 120.25M |
| 107 | GHRS | GH Research PLC | 1.89B | -1.22% | 140,247 | - |
| 108 | FTRE | Fortrea Holdings Inc. | 1.88B | 13.33% | 1,947,081 | 2.68B |
| 109 | COAG | Hemab Therapeutics Holdings, Inc. | 1.87B | -0.49% | 256,938 | - |
| 110 | BHVN | Biohaven Ltd. | 1.86B | -2.37% | 3,082,896 | - |
| 111 | ZYME | Zymeworks Inc. | 1.85B | -2.98% | 552,148 | 37.13M |
| 112 | STOK | Stoke Therapeutics, Inc. | 1.82B | -4.90% | 1,071,816 | 27.59M |
| 113 | SEPN | Septerna, Inc. | 1.81B | -1.74% | 269,392 | 98.88M |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.79B | 4.46% | 890,382 | 1.13B |
| 115 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.79B | 2.84% | 2,676,766 | 208.78M |
| 116 | NBTX | Nanobiotix S.A. | 1.77B | -0.98% | 135,729 | 38.27M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.77B | -3.06% | 2,284,809 | 303.23M |
| 118 | XNCR | Xencor, Inc. | 1.77B | -3.18% | 1,732,995 | 104.97M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.75B | 1.44% | 1,142,326 | - |
| 120 | KLRA | Kailera Therapeutics, Inc. | 1.74B | -2.18% | 726,406 | - |
| 121 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -4.99% | 11,881,322 | 54.86M |
| 122 | KARD | Kardigan, Inc. | 1.74B | -2.52% | 344,901 | - |
| 123 | BRVE | Braveheart Bio, Inc. | 1.71B | -1.15% | 274,956 | - |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 1.00% | 5,148,771 | 5.49M |
| 125 | IMCR | Immunocore Holdings plc | 1.64B | -2.11% | 653,904 | 430.78M |
| 126 | ANAB | AnaptysBio, Inc. | 1.62B | 1.05% | 351,768 | 232.39M |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | -1.42% | 1,128,103 | 252.25M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -4.30% | 3,990,812 | 59.51M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.55B | -4.40% | 251,600 | 1.30M |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.53B | -12.82% | 1,677,941 | - |
| 131 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 1.63% | 221,444 | - |
| 132 | NVAX | Novavax, Inc. | 1.52B | -3.75% | 3,331,570 | 413.80M |
| 133 | AVLN | Avalyn Pharma Inc. | 1.52B | -2.00% | 227,079 | - |
| 134 | INVA | Innoviva, Inc. | 1.51B | -0.29% | 1,102,032 | 440.00M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.50B | -2.28% | 706,493 | - |
| 136 | AAPG | Ascentage Pharma Group International | 1.46B | -2.50% | 4,287 | 94.61M |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.39B | -4.01% | 320,546 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -2.10% | 337,266 | - |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.37B | 2.40% | 526,049 | - |
| 140 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 3.26% | 412,397 | - |
| 141 | ABSI | Absci Corporation | 1.36B | -1.85% | 2,331,809 | 1.56M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.35B | -1.78% | 437,398 | 20.00M |
| 143 | SVRA | Savara Inc. | 1.34B | -1.50% | 1,301,414 | - |
| 144 | CGEM | Cullinan Therapeutics, Inc. | 1.32B | 0.69% | 1,060,744 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.32B | -3.29% | 729,843 | - |
| 146 | RARE | Ultragenyx Pharmaceutical Inc. | 1.28B | -3.97% | 5,655,000 | 717.00M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.28B | -2.29% | 2,052,551 | - |
| 148 | AKTS | Aktis Oncology, Inc. | 1.25B | -3.28% | 290,429 | 10.06M |
| 149 | OMER | Omeros Corporation | 1.24B | -1.66% | 1,655,522 | 38.42M |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.23B | -7.04% | 158,967 | - |
| 151 | REPL | Replimune Group, Inc. | 1.23B | -0.61% | 2,233,135 | - |
| 152 | MGTX | MeiraGTx Holdings plc | 1.23B | -0.93% | 1,025,613 | 397.50M |
| 153 | ANRO | Alto Neuroscience, Inc. | 1.19B | -4.51% | 420,380 | - |
| 154 | IMTX | Immatics N.V. | 1.18B | -0.23% | 355,788 | 47.65M |
| 155 | MNKD | MannKind Corporation | 1.14B | -5.07% | 3,698,100 | 393.63M |
| 156 | GLUE | Monte Rosa Therapeutics, Inc. | 1.11B | -6.55% | 1,126,073 | 28.73M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.11B | -4.40% | 849,771 | - |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -1.22% | 1,397,081 | - |
| 159 | SLBT | SL Science Holding Limited | 1.09B | -7.73% | 60,846 | 3.27M |
| 160 | ALMS | Alumis Inc. | 1.09B | -8.89% | 4,004,535 | 7.40M |
| 161 | ATTO | Attovia Therapeutics, Inc. | 1.08B | -3.34% | 198,400 | 1.80M |
| 162 | APMD | Apnimed, Inc. | 1.06B | 0.04% | 350,383 | 115.12M |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 1.05B | -9.36% | 274,331 | 99.00K |
| 164 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -6.08% | 472,266 | - |
| 165 | MLTX | MoonLake Immunotherapeutics | 1.04B | -3.79% | 1,797,994 | - |
| 166 | KURA | Kura Oncology, Inc. | 1.01B | -2.25% | 1,827,283 | 77.23M |
| 167 | JANX | Janux Therapeutics, Inc. | 1.01B | -5.03% | 1,008,478 | 24.00M |
| 168 | ABUS | Arbutus Biopharma Corporation | 1.00B | -1.36% | 4,252,429 | 181.72M |
| 169 | SGP | SpyGlass Pharma, Inc. | 968.65M | 1.05% | 131,672 | - |
| 170 | ANL | Adlai Nortye Group Ltd. | 963.39M | -6.09% | 171,304 | 18.06M |
| 171 | HELP | Cybin Inc. | 958.55M | -3.60% | 1,195,675 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 945.98M | -1.25% | 2,472,695 | - |
| 173 | IVA | Inventiva S.A. | 936.99M | -0.52% | 2,633,766 | 7.94M |
| 174 | FTH | Faeth Therapeutics, Inc. | 913.98M | -9.52% | 209,046 | - |
| 175 | SLDB | Solid Biosciences Inc. | 897.48M | -4.23% | 1,514,321 | - |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 894.36M | 1.52% | 2,508,530 | 41.47M |
| 177 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 403,744 | 104.31M |
| 178 | WVE | Wave Life Sciences, Inc. | 878.83M | -2.62% | 2,286,378 | 65.37M |
| 179 | IMMX | Immix Biopharma, Inc. | 868.49M | -0.57% | 1,054,947 | - |
| 180 | AVTX | Avalo Therapeutics, Inc. | 861.83M | -0.68% | 1,102,736 | 59.00K |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 855.73M | -4.96% | 1,733,327 | - |
| 182 | CADL | Candel Therapeutics, Inc. | 850.89M | 4.12% | 1,065,371 | - |
| 183 | ARDX | Ardelyx, Inc. | 847.24M | -3.41% | 5,095,868 | 450.89M |
| 184 | GERN | Geron Corporation | 841.64M | -4.38% | 16,486,722 | 204.56M |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 828.64M | -2.18% | 269,844 | 276.79M |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 813.27M | -2.04% | 1,331,161 | 8.22M |
| 187 | CBIO | Crescent Biopharma, Inc. | 804.66M | -4.47% | 357,961 | 11.88M |
| 188 | CLYM | Climb Bio, Inc. | 798.94M | -4.46% | 1,552,836 | - |
| 189 | DSGN | Design Therapeutics, Inc. | 765.06M | -9.58% | 1,280,322 | - |
| 190 | ACHV | Achieve Life Sciences, Inc. | 753.25M | 1.24% | 1,385,040 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 752.98M | -0.94% | 552,035 | 92.01M |
| 192 | SLN | Silence Therapeutics plc | 750.21M | -4.59% | 1,235,925 | 615.00K |
| 193 | PHAR | Pharming Group N.V. | 743.57M | -2.50% | 15,274 | 366.48M |
| 194 | ANNX | Annexon, Inc. | 743.15M | -0.76% | 2,960,538 | - |
| 195 | AURA | Aura Biosciences, Inc. | 717.64M | -1.28% | 712,284 | - |
| 196 | NVCT | Nuvectis Pharma, Inc. | 714.19M | -6.12% | 166,135 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 709.37M | - | 97,726 | 109.82M |
| 198 | DBVT | DBV Technologies S.A. | 707.16M | -4.78% | 175,072 | 5.04M |
| 199 | MNPR | Monopar Therapeutics Inc. | 700.28M | -3.68% | 96,983 | - |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -3.32% | 916,533 | 136.07M |
| 201 | MDXG | MiMedx Group, Inc. | 687.99M | 1.72% | 1,147,376 | 355.17M |
| 202 | BLSM | BlossomHill Therapeutics, Inc. | 679.37M | 1.98% | 148,830 | - |
| 203 | NGNE | Neurogene Inc. | 674.18M | -4.32% | 147,589 | 925.00K |
| 204 | MPLT | MapLight Therapeutics, Inc. | 671.35M | -8.14% | 402,324 | - |
| 205 | VSTM | Verastem, Inc. | 664.74M | -2.26% | 2,840,151 | 87.53M |
| 206 | SGMT | Sagimet Biosciences Inc. | 650.18M | -3.86% | 852,725 | - |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 648.15M | -5.99% | 1,641,913 | 239.66M |
| 208 | OABI | OmniAb, Inc. | 632.45M | -2.90% | 788,806 | 38.46M |
| 209 | ALT | Altimmune, Inc. | 628.29M | -2.12% | 2,339,039 | 31.00K |
| 210 | OCS | Oculis Holding AG | 621.64M | -5.00% | 159,306 | 1.45M |
| 211 | VALN | Valneva SE | 617.63M | -1.95% | 23,769 | 163.30M |
| 212 | CRMD | CorMedix Inc. | 604.85M | -1.65% | 718,700 | 462.25M |
| 213 | AGMB | AgomAb Therapeutics NV | 601.81M | -0.49% | 146,342 | - |
| 214 | SCTX | Scribe Therapeutics Inc. | 599.38M | 7.61% | 162,610 | 33.30M |
| 215 | STTK | Shattuck Labs, Inc. | 599.17M | -3.71% | 895,232 | 1.00M |
| 216 | ALLO | Allogene Therapeutics, Inc. | 594.24M | -3.37% | 3,138,542 | 4.64M |
| 217 | DRUG | Bright Minds Biosciences Inc. | 593.45M | -4.99% | 58,915 | - |
| 218 | CTMX | CytomX Therapeutics, Inc. | 586.15M | -15.94% | 7,509,835 | 18.30M |
| 219 | PRME | Prime Medicine, Inc. | 558.62M | -1.26% | 2,574,422 | 4.07M |
| 220 | TECX | Tectonic Therapeutic, Inc. | 557.35M | -4.04% | 220,898 | - |
| 221 | ARVN | Arvinas, Inc. | 540.09M | -1.67% | 2,523,096 | 316.70M |
| 222 | ASMB | Assembly Biosciences, Inc. | 531.62M | -9.84% | 588,837 | 74.85M |
| 223 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.39M | 0.50% | 197,825 | - |
| 224 | OVID | Ovid Therapeutics Inc. | 529.26M | -1.09% | 988,533 | 1.58M |
| 225 | PROK | ProKidney Corp. | 526.04M | -3.87% | 1,201,056 | 818.00K |
| 226 | RGNX | REGENXBIO Inc. | 524.47M | -8.57% | 1,427,110 | 174.48M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 519.92M | -6.75% | 704,608 | - |
| 228 | EIKN | Eikon Therapeutics, Inc. | 514.03M | 1.39% | 843,447 | - |
| 229 | AUTL | Autolus Therapeutics plc | 503.05M | -2.58% | 978,726 | 117.39M |
| 230 | CAPR | Capricor Therapeutics, Inc. | 497.67M | -2.84% | 2,174,659 | 11.13M |
| 231 | ENTX | Entera Bio Ltd. | 495.19M | 1.42% | 391,293 | 42.00K |
| 232 | INDP | Indaptus Therapeutics, Inc. | 485.00M | 15.92% | 1,960,465 | - |
| 233 | IRD | Opus Genetics, Inc. | 484.20M | -2.51% | 1,993,223 | 9.86M |
| 234 | PBYI | Puma Biotechnology, Inc. | 477.49M | 1.20% | 309,915 | 231.24M |
| 235 | RLMD | Relmada Therapeutics, Inc. | 473.61M | - | 1,998,601 | - |
| 236 | ZURA | Zura Bio Limited | 472.44M | -5.37% | 2,637,350 | - |
| 237 | DNA | Ginkgo Bioworks Holdings, Inc. | 470.71M | -0.29% | 734,926 | 132.42M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 465.54M | -1.53% | 262,713 | 22.42M |
| 239 | ARCT | Arcturus Therapeutics Holdings Inc. | 450.22M | 3.60% | 556,075 | 29.37M |
| 240 | VOGX | Vogenx, Inc. | 448.29M | -0.65% | 149,862 | - |
| 241 | CABA | Cabaletta Bio, Inc. | 439.97M | -10.82% | 7,237,843 | - |
| 242 | ARTV | Artiva Biotherapeutics, Inc. | 435.61M | -12.13% | 584,555 | 251.00K |
| 243 | RZLT | Rezolute, Inc. | 433.54M | -2.35% | 752,958 | - |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 430.43M | -5.95% | 1,070,875 | - |
| 245 | PRTA | Prothena Corporation plc | 427.64M | -5.98% | 323,436 | 54.53M |
| 246 | SPRY | ARS Pharmaceuticals, Inc. | 422.65M | -5.56% | 2,776,215 | 116.93M |
| 247 | CCCC | C4 Therapeutics, Inc. | 421.98M | - | 1,344,577 | 35.04M |
| 248 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | -3.35% | 480,800 | 1.00 |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 419.47M | -1.69% | 224,327 | - |
| 250 | LRMR | Larimar Therapeutics, Inc. | 408.14M | 3.44% | 856,560 | - |
| 251 | EDIT | Editas Medicine, Inc. | 403.92M | -4.01% | 1,681,526 | 47.01M |
| 252 | TTRX | Turn Therapeutics Inc. | 400.95M | 0.07% | 85,171 | - |
| 253 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 391.25M | -3.37% | 629,201 | - |
| 254 | BNTC | Benitec Biopharma Inc. | 385.45M | -8.53% | 263,420 | - |
| 255 | VTVT | vTv Therapeutics Inc. | 378.46M | -3.12% | 45,333 | 36.84M |
| 256 | GALT | Galectin Therapeutics Inc. | 376.17M | -2.86% | 327,232 | - |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 374.33M | -0.58% | 3,660,970 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 373.11M | -0.75% | 253,698 | 59.22M |
| 259 | OBIO | Orchestra BioMed Holdings, Inc. | 363.03M | 2.37% | 228,736 | 31.98M |
| 260 | EVMN | Evommune, Inc. | 362.56M | -4.22% | 520,000 | 10.00M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 358.91M | - | 2,081,086 | 15.85M |
| 262 | IPSC | Century Therapeutics, Inc. | 358.53M | -1.00% | 359,638 | 109.16M |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 357.95M | -6.33% | 284,878 | 65.26M |
| 264 | DMAC | DiaMedica Therapeutics Inc. | 352.13M | -0.31% | 157,942 | - |
| 265 | PALI | Palisade Bio, Inc. | 351.16M | -1.71% | 4,489,418 | 500.00K |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 338.84M | -1.90% | 888,378 | - |
| 267 | OCGN | Ocugen, Inc. | 336.91M | -6.27% | 12,645,332 | 4.58M |
| 268 | CMPX | Compass Therapeutics, Inc. | 333.16M | -5.61% | 2,440,059 | 850.00K |
| 269 | QTTB | Q32 Bio Inc. | 332.52M | 2.38% | 602,516 | 53.74M |
| 270 | AGEN | Agenus Inc. | 322.35M | 0.42% | 779,379 | 132.69M |
| 271 | EYPT | EyePoint, Inc. | 315.54M | -13.88% | 3,894,199 | 2.79M |
| 272 | ABEO | Abeona Therapeutics Inc. | 312.80M | 0.74% | 1,934,770 | 25.52M |
| 273 | SION | Sionna Therapeutics, Inc. | 311.06M | -16.71% | 2,462,370 | - |
| 274 | SABS | SAB Biotherapeutics, Inc. | 310.26M | -1.45% | 284,181 | 114.70K |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 301.71M | -3.11% | 758,872 | 215.72M |
| 276 | CUVL | Clinuvel Pharmaceuticals Limited | 300.65M | 1.36% | 20,504 | 65.05M |
| 277 | UPB | Upstream Bio, Inc. | 300.15M | -5.68% | 421,157 | 3.16M |
| 278 | IFRX | InflaRx N.V. | 297.68M | -4.72% | 579,505 | -11.54K |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 296.32M | -10.57% | 1,398,555 | 26.87M |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 295.51M | -4.12% | 20,276 | 412.09K |
| 281 | FULC | Fulcrum Therapeutics, Inc. | 288.40M | -0.26% | 1,326,975 | 80.00M |
| 282 | IMRX | Immuneering Corporation | 287.26M | 2.54% | 862,315 | - |
| 283 | FATE | Fate Therapeutics, Inc. | 281.58M | 0.43% | 828,371 | 6.49M |
| 284 | YDES | YD Bio Limited | 277.76M | 3.13% | 688,666 | 1.24M |
| 285 | PYXS | Pyxis Oncology, Inc. | 277.75M | -2.92% | 489,638 | 11.04M |
| 286 | STRO | Sutro Biopharma, Inc. | 274.58M | -2.07% | 1,294,180 | 45.70M |
| 287 | LCTX | Lineage Cell Therapeutics, Inc. | 268.08M | -0.93% | 1,400,035 | 13.08M |
| 288 | LYEL | Lyell Immunopharma, Inc. | 267.35M | -3.71% | 184,121 | 27.00K |
| 289 | ACIU | AC Immune SA | 266.46M | 0.71% | 93,528 | 21.67M |
| 290 | CAMP | Camp4 Therapeutics Corporation | 262.94M | -1.41% | 175,272 | 4.22M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 261.34M | -1.82% | 758,966 | - |
| 292 | PRQR | ProQR Therapeutics N.V. | 259.66M | -1.08% | 721,636 | 21.05M |
| 293 | MGNX | MacroGenics, Inc. | 257.35M | -3.81% | 264,969 | 175.14M |
| 294 | BCYC | Bicycle Therapeutics plc | 256.87M | -5.66% | 544,655 | 61.21M |
| 295 | TRDA | Entrada Therapeutics, Inc. | 248.07M | -2.41% | 247,693 | 4.69M |
| 296 | FHTX | Foghorn Therapeutics Inc. | 244.67M | -5.50% | 467,622 | 36.74M |
| 297 | IVVD | Invivyd, Inc. | 244.65M | -6.93% | 4,234,849 | 58.37M |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 238.71M | -1.87% | 113,268 | 1.48M |
| 299 | YARW | Yarrow Bioscience, Inc. | 237.26M | -2.89% | 80,270 | - |
| 300 | GLSI | Greenwich LifeSciences, Inc. | 236.17M | 0.25% | 96,834 | - |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 233.17M | 0.49% | 142,334 | 7.15M |
| 302 | NGEN | NervGen Pharma Corp. | 230.10M | -2.51% | 317,670 | - |
| 303 | CUE | Cue Biopharma, Inc. | 229.85M | 3.57% | 127,172 | 37.66M |
| 304 | CGEN | Compugen Ltd. | 228.29M | -2.62% | 330,760 | 74.00M |
| 305 | ALEC | Alector, Inc. | 227.22M | -7.92% | 715,903 | 13.86M |
| 306 | AVXL | Anavex Life Sciences Corp. | 226.18M | -6.15% | 946,232 | - |
| 307 | TARA | Protara Therapeutics, Inc. | 221.61M | -4.09% | 901,081 | - |
| 308 | KROS | Keros Therapeutics, Inc. | 221.47M | -0.36% | 199,980 | 15.01M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 220.44M | -2.17% | 806,308 | - |
| 310 | VRXA | Veraxa Biotech AG | 214.94M | -6.75% | 52,198 | 29.54K |
| 311 | PLX | Protalix BioTherapeutics, Inc. | 214.32M | -3.97% | 812,742 | 80.62M |
| 312 | SLGL | Sol-Gel Technologies Ltd. | 210.85M | -1.20% | 59,104 | 1.80M |
| 313 | ABOS | Acumen Pharmaceuticals, Inc. | 209.00M | 3.58% | 359,311 | - |
| 314 | SRZN | Surrozen, Inc. | 208.86M | -0.39% | 151,938 | 11.51M |
| 315 | KRRO | Korro Bio, Inc. | 207.19M | 1.37% | 162,589 | 2.38M |
| 316 | NKTX | Nkarta, Inc. | 206.28M | -1.37% | 458,356 | - |
| 317 | CHRS | Coherus Oncology, Inc. | 205.49M | -6.99% | 761,956 | 50.94M |
| 318 | ANTX | AN2 Therapeutics, Inc. | 202.27M | -1.83% | 156,796 | - |
| 319 | PEPG | PepGen Inc. | 200.16M | -2.69% | 567,274 | - |
| 320 | ADAG | Adagene Inc. | 199.42M | -9.17% | 626,106 | 9.29M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 199.29M | -0.94% | 288,313 | 29.10M |
| 322 | MSLE | Satellos Bioscience Inc. | 198.33M | -4.49% | 16,859 | - |
| 323 | ORMP | Oramed Pharmaceuticals Inc. | 192.18M | -1.07% | 145,851 | 2.00M |
| 324 | ACOG | Alpha Cognition Inc. | 191.65M | 1.03% | 135,626 | 15.26M |
| 325 | VYGR | Voyager Therapeutics, Inc. | 190.40M | -3.13% | 451,952 | 34.46M |
| 326 | NBP | NovaBridge Biosciences | 184.44M | -1.24% | 279,506 | - |
| 327 | NERV | Minerva Neurosciences, Inc. | 182.87M | -4.49% | 287,170 | - |
| 328 | DTIL | Precision BioSciences, Inc. | 182.45M | -3.64% | 314,595 | 45.06M |
| 329 | MDWD | MediWound Ltd. | 173.90M | -2.95% | 80,526 | 11.86M |
| 330 | RNA | Atrium Therapeutics, Inc. | 172.60M | -1.18% | 274,562 | 35.84M |
| 331 | IPHA | Innate Pharma S.A. | 167.85M | 0.54% | 47,787 | 10.57M |
| 332 | OTLK | Outlook Therapeutics, Inc. | 163.84M | 5.50% | 4,516,322 | -1.16M |
| 333 | ARMP | Armata Pharmaceuticals, Inc. | 163.60M | -20.72% | 650,233 | 5.54M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 162.95M | -2.62% | 625,174 | 1.50M |
| 335 | SPRB | Spruce Biosciences, Inc. | 158.54M | -2.96% | 110,112 | 697.00K |
| 336 | MOLN | Molecular Partners AG | 157.60M | 4.48% | 3,672 | 856.30K |
| 337 | MENS | Jyong Biotech Ltd. | 157.37M | 1.92% | 36,539 | - |
| 338 | NMRA | Neumora Therapeutics, Inc. | 156.20M | -16.82% | 1,420,267 | - |
| 339 | CDXS | Codexis, Inc. | 153.31M | -5.41% | 608,718 | 77.68M |
| 340 | HUMA | Humacyte, Inc. | 153.23M | -1.68% | 3,212,176 | 2.12M |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 150.35M | -3.23% | 1,841,322 | 1.34M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 147.09M | -2.58% | 1,257,746 | 3.39M |
| 343 | KZIA | Kazia Therapeutics Limited | 141.97M | -7.17% | 495,835 | 1.27M |
| 344 | IMUX | Immunic, Inc. | 141.49M | -7.66% | 287,809 | - |
| 345 | CRBU | Caribou Biosciences, Inc. | 136.15M | -1.55% | 1,692,439 | 10.04M |
| 346 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 133.84M | -14.36% | 3,756,933 | - |
| 347 | LENZ | LENZ Therapeutics, Inc. | 132.91M | -5.37% | 819,685 | 21.48M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 131.20M | -8.54% | 1,691,133 | - |
| 349 | MIST | Milestone Pharmaceuticals Inc. | 130.72M | -2.29% | 1,948,020 | 2.34M |
| 350 | BMEA | Biomea Fusion, Inc. | 130.47M | 1.12% | 1,344,127 | - |
| 351 | EQ | Equillium, Inc. | 129.99M | -2.15% | 231,195 | 4.39M |
| 352 | HURA | TuHURA Biosciences, Inc. | 129.37M | -0.98% | 132,258 | - |
| 353 | ENGN | enGene Therapeutics Inc. | 126.66M | 1.07% | 618,704 | - |
| 354 | CBUS | Cibus, Inc. | 120.76M | 5.37% | 236,775 | 4.35M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 119.94M | -1.69% | 2,647,925 | 65.34K |
| 356 | CNXU | Conexeu Sciences Inc. | 119.07M | -11.00% | 124,778 | - |
| 357 | OKUR | OnKure Therapeutics, Inc. | 118.65M | -2.33% | 171,101 | - |
| 358 | PMN | ProMIS Neurosciences, Inc. | 115.59M | -2.79% | 49,071 | - |
| 359 | RANI | Rani Therapeutics Holdings, Inc. | 114.51M | -1.71% | 733,971 | 4.88M |
| 360 | NAUT | Nautilus Biotechnology, Inc. | 113.40M | -1.68% | 944,975 | 190.00K |
| 361 | CLLS | Cellectis S.A. | 113.30M | -12.02% | 781,019 | 63.82M |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 113.18M | -2.96% | 301,753 | 70.00M |
| 363 | VANI | Vivani Medical, Inc. | 110.95M | -2.38% | 208,637 | - |
| 364 | GNLX | Genelux Corporation | 110.69M | -2.76% | 203,404 | 8.00K |
| 365 | TLSA | Tiziana Life Sciences Ltd | 110.17M | -4.29% | 659,464 | - |
| 366 | AARD | Aardvark Therapeutics, Inc. | 109.86M | -9.55% | 64,147 | - |
| 367 | COYA | Coya Therapeutics, Inc. | 109.08M | 0.22% | 215,170 | 8.02M |
| 368 | SEER | Seer, Inc. | 105.21M | -0.52% | 181,450 | 14.22M |
| 369 | TENX | Tenax Therapeutics, Inc. | 104.83M | -1.61% | 1,647,354 | - |
| 370 | PYPD | PolyPid Ltd. | 104.81M | -3.19% | 81,667 | - |
| 371 | CRDF | Cardiff Oncology, Inc. | 104.25M | 2.29% | 3,168,469 | 508.00K |
| 372 | PMVP | PMV Pharmaceuticals, Inc. | 102.70M | -6.85% | 705,715 | - |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 101.94M | 1.24% | 17,066 | - |
| 374 | ONCY | Oncolytics Biotech Inc. | 99.46M | -4.02% | 909,770 | - |
| 375 | MNOV | MediciNova, Inc. | 99.43M | 8.02% | 207,119 | 920.48K |
| 376 | CGTX | Cognition Therapeutics, Inc. | 98.42M | 2.48% | 627,287 | - |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 94.76M | 2.05% | 56,061 | 6.19M |
| 378 | ACET | Adicet Bio, Inc. | 91.55M | -12.32% | 479,239 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 91.52M | -3.93% | 353,656 | - |
| 380 | RLYB | Rallybio Corporation | 91.45M | 4.30% | 22,168 | 646.00K |
| 381 | GUTS | Fractyl Health, Inc. | 89.94M | -7.62% | 1,740,596 | 3.00K |
| 382 | ICCC | ImmuCell Corporation | 87.01M | -1.34% | 20,891 | 30.68M |
| 383 | FBIO | Fortress Biotech, Inc. | 83.04M | -1.58% | 225,319 | 68.47M |
| 384 | NTRB | Nutriband Inc. | 82.90M | -1.59% | 45,543 | 1.62M |
| 385 | ALDX | Aldeyra Therapeutics, Inc. | 82.65M | -6.16% | 833,571 | - |
| 386 | NTHI | NeOnc Technologies Holdings, Inc. | 82.28M | -12.43% | 285,802 | 39.99K |
| 387 | OSTX | OS Therapies Incorporated | 82.10M | 4.71% | 1,053,387 | - |
| 388 | MAIA | MAIA Biotechnology, Inc. | 81.51M | -3.60% | 1,186,176 | - |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | - | 27,408 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 78.68M | -4.18% | 46,439 | 30.32M |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 78.42M | -6.63% | 304,393 | - |
| 392 | PTHS | Pelthos Therapeutics Inc. | 77.79M | -7.38% | 71,509 | 43.30M |
| 393 | RNXT | RenovoRx, Inc. | 77.62M | 1.78% | 1,032,461 | 1.98M |
| 394 | IBIO | iBio, Inc. | 76.53M | -0.83% | 375,735 | 100.00K |
| 395 | KLRS | Kalaris Therapeutics, Inc. | 76.18M | -3.03% | 109,363 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 74.63M | -1.72% | 215,691 | - |
| 397 | CING | Cingulate Inc. | 74.31M | -1.16% | 58,038 | - |
| 398 | CNTB | Connect Biopharma Holdings Limited | 73.68M | -32.17% | 11,685,590 | 2.95M |
| 399 | ELOX | Eloxx Pharmaceuticals, Inc. | 73.67M | 12.15% | 40,690 | - |
| 400 | NRXS | NeurAxis, Inc. | 71.58M | -0.87% | 77,312 | 5.32M |
| 401 | BSEM | BioStem Technologies, Inc. | 71.58M | -4.75% | 117,036 | 34.59M |
| 402 | OKYO | OKYO Pharma Limited | 70.32M | -4.29% | 83,312 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 69.35M | -2.61% | 501,965 | - |
| 404 | LONA | LeonaBio, Inc. | 68.21M | -3.08% | 23,408 | - |
| 405 | CSBR | Champions Oncology, Inc. | 67.04M | -1.93% | 30,184 | 60.66M |
| 406 | XBIT | XBiotech Inc. | 66.92M | 1.15% | 18,231 | - |
| 407 | ATHE | Alterity Therapeutics Limited | 66.89M | -9.33% | 14,571 | 2.50M |
| 408 | ALPS | Alps Group Inc | 66.56M | - | 108,784 | 3.74M |
| 409 | SPRO | Spero Therapeutics, Inc. | 65.81M | -0.88% | 225,284 | 47.00M |
| 410 | BOLD | Boundless Bio, Inc. | 64.03M | -0.88% | 23,225 | - |
| 411 | GOSS | Gossamer Bio, Inc. | 63.43M | -2.99% | 219,514 | 53.29M |
| 412 | INMB | INmune Bio Inc. | 62.72M | -3.00% | 350,249 | 50.00K |
| 413 | RNTX | Rein Therapeutics Inc. | 61.03M | -10.56% | 556,115 | - |
| 414 | EXOZ | eXoZymes, Inc. | 61.02M | 4.70% | 11,159 | -700.00 |
| 415 | SER | Serina Therapeutics, Inc. | 59.69M | -4.08% | 31,877 | 130.00K |
| 416 | HRTX | Heron Therapeutics, Inc. | 59.61M | -0.41% | 1,495,399 | 151.18M |
| 417 | XLO | Xilio Therapeutics, Inc. | 59.22M | 0.78% | 17,348 | 64.09M |
| 418 | DWTX | Dogwood Therapeutics, Inc. | 58.81M | -6.23% | 31,841 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 58.23M | -4.68% | 15,768 | - |
| 420 | IBO | Impact BioMedical Inc. | 57.04M | 9.27% | 121,747 | 35.00K |
| 421 | IMA | ImageneBio, Inc. | 56.47M | -0.50% | 14,249 | 800.00K |
| 422 | EDSA | Edesa Biotech, Inc. | 55.67M | -0.36% | 34,996 | - |
| 423 | HYFT | MindWalk Holdings Corp. | 54.27M | -13.16% | 562,295 | 11.57M |
| 424 | APLM | Apollomics, Inc. | 52.75M | 3.62% | 6,251 | 8.84M |
| 425 | ELTX | Elicio Therapeutics, Inc. | 52.30M | -0.50% | 318,931 | - |
| 426 | CLNN | Clene Inc. | 51.65M | 22.56% | 479,022 | 197.00K |
| 427 | HYPD | Hyperion DeFi, Inc. | 51.12M | -9.62% | 380,945 | 1.40M |
| 428 | TVGN | Tevogen Inc. | 50.46M | 3.20% | 2,594 | - |
| 429 | TIL | Instil Bio, Inc. | 48.97M | -3.09% | 17,340 | - |
| 430 | ANVS | Annovis Bio, Inc. | 47.72M | -1.75% | 824,332 | - |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | 2.31% | 1,207,952 | 21.00M |
| 432 | IMMP | Immutep Limited | 47.30M | -0.24% | 368,428 | 13.79M |
| 433 | GRCE | Grace Therapeutics, Inc. | 46.91M | -2.62% | 66,198 | - |
| 434 | MCRB | Seres Therapeutics, Inc. | 45.73M | -2.75% | 44,825 | 1.88M |
| 435 | MREO | Mereo BioPharma Group plc | 45.51M | 1.79% | 887,307 | 500.00K |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 43.82M | -2.52% | 160,368 | 13.56M |
| 437 | VERU | Veru Inc. | 39.90M | - | 125,287 | 16.89M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 39.30M | -2.34% | 96,168 | 35.09M |
| 439 | ATYR | aTyr Pharma, Inc. | 38.18M | 0.15% | 1,059,982 | 190.00K |
| 440 | LITS | Lite Strategy, Inc. | 37.09M | -5.22% | 318,725 | - |
| 441 | CRVO | CervoMed Inc. | 37.04M | -3.16% | 106,805 | 331.30K |
| 442 | CELU | Celularity Inc. | 35.89M | -11.43% | 149,410 | 26.55M |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 34.93M | -3.75% | 1,329,482 | 146.62M |
| 444 | FLNA | Filana Therapeutics, Inc. | 33.65M | -3.10% | 446,347 | - |
| 445 | CNTX | Context Therapeutics Inc. | 33.48M | 3.82% | 1,376,491 | - |
| 446 | PDSB | PDS Biotechnology Corporation | 32.76M | 46.65% | 372,175,042 | - |
| 447 | KYNB | Kyntra Bio, Inc. | 31.42M | -3.36% | 12,093 | 4.62M |
| 448 | ALGS | Aligos Therapeutics, Inc. | 31.16M | -0.99% | 34,484 | 31.52M |
| 449 | BYSI | BeyondSpring Inc. | 30.86M | -1.25% | 18,882 | 1.88M |
| 450 | BCTX | BriaCell Therapeutics Corp. | 30.76M | 0.56% | 68,781 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 29.34M | 0.89% | 15,930 | - |
| 452 | NXTC | NextCure, Inc. | 29.16M | -4.07% | 157,559 | - |
| 453 | QNTM | Quantum BioPharma Ltd. | 27.98M | - | 103,597 | - |
| 454 | ABVC | ABVC BioPharma, Inc. | 27.74M | 7.00% | 287,893 | 797.92K |
| 455 | IGC | IGC Pharma, Inc. | 27.59M | -3.12% | 502,176 | 1.11M |
| 456 | RNAZ | TransCode Therapeutics, Inc. | 27.09M | -3.03% | 18,516 | - |
| 457 | ESLA | Estrella Immunopharma, Inc. | 26.58M | -3.86% | 48,131 | - |
| 458 | CVM | CEL-SCI Corporation | 26.03M | -2.63% | 95,497 | - |
| 459 | EVAX | Evaxion A/S | 25.35M | -0.98% | 11,165 | 7.49M |
| 460 | RADX | Radiopharm Theranostics Limited | 24.75M | -24.38% | 164,326 | 9.34M |
| 461 | PLRZ | Polyrizon Ltd. | 23.97M | 0.62% | 1,316 | - |
| 462 | NNVC | NanoViricides, Inc. | 23.92M | - | 752,039 | - |
| 463 | ATOS | Atossa Therapeutics, Inc. | 23.65M | -4.44% | 43,775 | - |
| 464 | ACTU | Actuate Therapeutics, Inc. | 23.62M | -4.50% | 148,395 | - |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 23.48M | -3.83% | 115,657 | - |
| 466 | PBM | Psyence Biomedical Ltd. | 23.15M | 1.17% | 68,489 | - |
| 467 | PTN | Palatin Technologies, Inc. | 22.42M | -18.11% | 147,643 | 12.88M |
| 468 | COCP | Cocrystal Pharma, Inc. | 22.06M | -2.14% | 33,984 | 330.00K |
| 469 | CLRB | Cellectar Biosciences, Inc. | 21.93M | 0.43% | 33,367 | - |
| 470 | LGVN | Longeveron Inc. | 21.87M | -0.87% | 44,163 | 1.19M |
| 471 | TCRX | TScan Therapeutics, Inc. | 21.78M | 4.90% | 679,157 | 7.11M |
| 472 | LTRN | Lantern Pharma Inc. | 21.73M | -0.58% | 128,115 | - |
| 473 | GRDX | GridAI Technologies Corp. | 21.44M | 1.96% | 61,987 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 20.54M | - | 17,460 | -13.27K |
| 475 | AKTX | Akari Therapeutics, Plc | 19.54M | -9.08% | 27,586 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 19.51M | - | 11,976 | 3.55M |
| 477 | NCEL | NewcelX Ltd. | 19.18M | 1.22% | 2,782 | - |
| 478 | JSPR | Jasper Therapeutics, Inc. | 18.97M | -9.91% | 402,555 | - |
| 479 | BCDA | BioCardia, Inc. | 18.62M | 3.36% | 519,843 | 3.00K |
| 480 | LPCN | Lipocine Inc. | 18.01M | -1.58% | 50,450 | 1.57M |
| 481 | CMMB | Chemomab Therapeutics Ltd. | 17.90M | 0.82% | 50,856 | - |
| 482 | ALLR | Allarity Therapeutics, Inc. | 17.66M | -5.13% | 155,658 | 345.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 16.71M | -1.96% | 280,399 | - |
| 484 | GTBP | GT Biopharma, Inc. | 16.24M | -22.61% | 335,323 | - |
| 485 | CNSY | Cerenome, Inc. | 16.09M | -2.30% | 96,240 | 4.20M |
| 486 | DYAI | Dyadic International, Inc. | 15.59M | 0.80% | 377,843 | 3.80M |
| 487 | ENLV | Enlivex Ltd. | 15.43M | 2.11% | 229,422 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 15.38M | -2.27% | 128,970 | 7.11M |
| 489 | PASG | Passage Bio, Inc. | 15.35M | -1.85% | 9,816 | - |
| 490 | NIKI | Niki BioSolutions, Inc. | 14.90M | -13.18% | 47,306 | - |
| 491 | MBRX | Moleculin Biotech, Inc. | 14.64M | -3.04% | 475,428 | - |
| 492 | PLUR | Pluri Inc. | 14.50M | -5.31% | 12,874 | 1.02M |
| 493 | HIND | Vyome Holdings, Inc. | 14.11M | -2.43% | 7,811 | 129.73K |
| 494 | LSTA | Lisata Therapeutics, Inc. | 13.88M | -1.28% | 157,862 | 100.00K |
| 495 | MLEC | Moolec Science SA | 13.78M | -6.68% | 33,458 | 7.83M |
| 496 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.66M | -1.16% | 38,997 | - |
| 497 | CALC | CalciMedica, Inc. | 13.52M | -1.00% | 55,047 | - |
| 498 | ICU | SeaStar Medical Holding Corporation | 13.31M | -1.66% | 29,170 | 1.71M |
| 499 | AEON | AEON Biopharma, Inc. | 13.25M | -7.20% | 2,083,422 | - |
| 500 | BIVI | BioVie Inc. | 13.20M | -14.63% | 1,154,667 | - |